Riccardo Castagnoli
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021/08/10 by Paul Bastard, Adrian Gervais, Tom Le Voyer +97 · 1 voice · 31 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #SARS-CoV-2 and COVID-19 Research #COVID-19 Clinical Research Studies #Diabetes and associated disorders
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020/09/24 by Paul Bastard, Lindsey B. Rosen, Qian Zhang +97 · 1 voice · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #COVID-19 Clinical Research Studies #Diabetes and associated disorders #SARS-CoV-2 and COVID-19 Research
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
2022/05/16 by Jérémy Manry, Paul Bastard, Adrian Gervais +97 · 1 voice · 5 citations
Medicine · #COVID-19 Clinical Research Studies #Long-Term Effects of COVID-19 #SARS-CoV-2 and COVID-19 Research
- The Use of Omics Sciences in Allergic Diseases From Bench to Bedside: An <scp>EAACI</scp> Position Paper
2025/07/02 by Chiara Tontini, Urszula Radzikowska, Carlos J. Aranda +20 · 1 voice · 1 citation
Medicine · #Allergic Rhinitis and Sensitization #Asthma and respiratory diseases #Dermatology and Skin Diseases